MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

LeMaitre Vascular Company Profile (NASDAQ:LMAT)

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.38 (36.27% upside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
Show:
DateFirmActionRatingPrice TargetActions
2/8/2016SidotiUpgradeNeutral -> Buy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2016SidotiInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2015Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Roth CapitalBoost Price TargetBuy$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Brean CapitalReiterated RatingBuy$15.00 -> $17.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Benchmark Co.Boost Price Target$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Canaccord GenuityReiterated RatingBuy$16.50 -> $18.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Stifel NicolausBoost Price TargetBuy$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Canaccord GenuityReiterated RatingBuy$14.50 -> $16.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Brean CapitalBoost Price TargetBuy$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Benchmark Co.Boost Price Target$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Barrington ResearchUpgradeMarket Perform -> Outperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2015Barrington ResearchInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Canaccord GenuityReiterated RatingBuy$14.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Benchmark Co.Boost Price TargetBuy$12.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Brean CapitalBoost Price TargetBuy$11.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Roth CapitalBoost Price TargetBuy$11.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Dougherty & CoInitiated CoverageBuy -> Buy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Roth CapitalReiterated RatingBuy$10.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Brean CapitalReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Canaccord GenuityBoost Price TargetBuy$12.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2015Canaccord GenuityReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalSet Price TargetBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015SidotiDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014Canaccord GenuityReiterated RatingBuy$11.50 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2014Stifel NicolausInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Brean CapitalInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014ING GroupInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/12/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha